Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Malignant Pleural Mesothelioma With Gene Modified Cancer Cell Lines

NCT00006216 is registered in ClinicalTrials.gov with Louisiana State University Health Sciences Center in New Orleans as lead sponsor.

NCT NCT00006216
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00006216 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Malignant Pleural Mesothelioma With Gene Modified Cancer Cell Lines
Lead sponsor
Louisiana State University Health Sciences Center in New Orleans
Phase
Phase 1
Overall status
Unknown status
Start date
August 31, 1997
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant mesothelioma